Merck KGaA (ETR:MRK – Get Free Report) was down 0.5% on Thursday . The company traded as low as €138.45 and last traded at €138.65. Approximately 112,448 shares traded hands during trading, The stock had previously closed at €139.35.
Merck KGaA Stock Performance
The firm’s fifty day moving average is €140.43 and its 200-day moving average is €126.66. The company has a current ratio of 1.69, a quick ratio of 0.72 and a debt-to-equity ratio of 40.77. The stock has a market capitalization of $61.75 billion, a PE ratio of 22.78, a price-to-earnings-growth ratio of 2.37 and a beta of 0.81.
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies.
Recommended Stories
- Five stocks we like better than Merck KGaA
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
